Arq. Bras. Oftalmol. 2020; 83 (2): 10.5935/0004-2749.20200029
Total: 1517
Ibrahim Inan Harbiyeli1; Altan A. Ozcan1; Arbil Acıkalin2; Emine Ciloglu3; Carol L. Shields4
DOI: 10.5935/0004-2749.20200029
1. Department of Ophthalmology, School of Medicine, Cukurova University, Adana, Turkey
2. Department of Pathology, School of Medicine, Cukurova University, Adana, Turkey
3. Department of Ophthalmology, University of Health Sciences, Adana City Training and Research Hospital, Adana, Turkey
4. Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA
Ibrahim Inan Harbiyeli
E-mail: [email protected]
Funding: This study received no specific financial support. The authors presented the informed consent of the patient.
Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
